2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

被引:412
作者
Heidenreich, Paul A.
Bozkurt, Biykem
Aguilar, David
Allen, Larry A.
Byun, Joni J.
Colvin, Monica M.
Deswal, Anita
Drazner, Mark H.
Dunlay, Shannon M.
Evers, Linda R.
Fang, James C.
Fedson, Savitri E.
Fonarow, Gregg C.
Hayek, Salim S.
Hernandez, Adrian F.
Khazanie, Prateeti
Kittleson, Michelle M.
Lee, Christopher S.
Link, Mark S.
Milano, Carmelo A.
Nnacheta, Lorraine C.
Sandhu, Alexander T.
Stevenson, Lynne Warner
Vardeny, Orly
Vest, Amanda R.
Yancy, Clyde W.
机构
关键词
AHA Scientific Statements; heart failure; heart failure with reduced ejection fraction; heart failure with preserved ejection fraction; heart failure with mildly reduced ejection fraction; systolic heart failure; heart failure rehabilitation; cardiac failure; chronic heart failure; acute decompensated heart failure; cardiogenic shock; beta blockers; mineralocorticoid receptor antagonists; ACE inhibitors; angiotensin and neprilysin receptor antagonist; sacubitril valsartan; angiotensin receptor antagonist; sodium glucose co-transporter 2; SGLT2; inhibitors; cardiac amyloidosis; atrial fibrillation; congestive heart failure; guideline-directed medical therapy; diabetes; cardiomyopathy; valvular heart disease; mitral regurgitation; cardiomyopathy in pregnancy; reduced ejection fraction; right heart pressure; palliative care; cardio-oncology; social determinants of health; LEFT-VENTRICULAR DYSFUNCTION; CARDIAC RESYNCHRONIZATION THERAPY; CONVERTING ENZYME-INHIBITORS; ACUTE MYOCARDIAL-INFARCTION; ATRIOVENTRICULAR JUNCTION ABLATION; PRESERVED EJECTION FRACTION; COST-EFFECTIVENESS ANALYSIS; ADAPTIVE SERVO-VENTILATION; INTENSIVE STATIN THERAPY; CORONARY-ARTERY-DISEASE;
D O I
10.1161/CIR.0000000000001062
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. Methods: A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases. Additional relevant clinical trials and research studies, published through September 2021, were also considered. This guideline was harmonized with other American Heart Association/American College of Cardiology guidelines published through December 2021. Structure: Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with heart failure, with the intent to improve quality of care and align with patients' interests. Many recommendations from the earlier heart failure guidelines have been updated with new evidence, and new recommendations have been created when supported by published data. Value statements are provided for certain treatments with high-quality published economic analyses.
引用
收藏
页码:E876 / E894
页数:19
相关论文
共 230 条
[1]   Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy [J].
Abu-Khalaf, Maysa M. ;
Safonov, Anton ;
Stratton, Jamie ;
Wang, Shiyi ;
Hatzis, Christos ;
Park, Esther ;
Pusztai, Lajos ;
Gross, Cary P. ;
Russell, Raymond .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) :261-270
[2]  
ACCF/AHA Task Force on Practice Guidelines, 2010, METH MAN POL ACCF AH
[3]   Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials [J].
Afilalo, Jonathan ;
Majdan, Agnieska A. ;
Eisenberg, Mark J. .
HEART, 2007, 93 (08) :914-921
[4]   Prediction of Incident Heart Failure in General Practice The Atherosclerosis Risk in Communities (ARIC) Study [J].
Agarwal, Sunil K. ;
Chambless, Lloyd E. ;
Ballantyne, Christie M. ;
Astor, Brad ;
Bertoni, Alain G. ;
Chang, Patricia P. ;
Folsom, Aaron R. ;
He, Max ;
Hoogeveen, Ron C. ;
Ni, Hanyu ;
Quibrera, Pedro M. ;
Rosamond, Wayne D. ;
Russell, Stuart D. ;
Shahar, Eyal ;
Heiss, Gerardo .
CIRCULATION-HEART FAILURE, 2012, 5 (04) :422-429
[5]   Protective effects of spironolactone against anthracycline-induced cardiomyopathy [J].
Akpek, Mahmut ;
Ozdogru, Ibrahim ;
Sahin, Omer ;
Inanc, Mevlude ;
Dogan, Ali ;
Yazici, Cevat ;
Berk, Veli ;
Karaca, Halit ;
Kalay, Nihat ;
Oguzhan, Abdurrahman ;
Ergin, Ali .
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (01) :81-89
[6]   Clinical and economic implications of the multicenter automatic defibrillator implantation trial-II [J].
Al-Khatib, SM ;
Anstrom, KJ ;
Eisenstein, EL ;
Peterson, ED ;
Jollis, JG ;
Mark, DB ;
Li, Y ;
O'Connor, CM ;
Shaw, LK ;
Califf, RM .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (08) :593-600
[7]   ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines [J].
Anderson, Jeffrey L. ;
Heidenreich, Paul A. ;
Barnett, Paul G. ;
Creager, Mark A. ;
Fonarow, Gregg C. ;
Gibbons, Raymond J. ;
Halperin, Jonathan L. ;
Hlatky, Mark A. ;
Jacobs, Alice K. ;
Mark, Daniel B. ;
Masoudi, Frederick A. ;
Peterson, Eric D. ;
Shaw, Leslee J. .
CIRCULATION, 2014, 129 (22) :2329-+
[8]   Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure [J].
Angus, DC ;
Linde-Zwirble, WT ;
Tam, SW ;
Ghali, JK ;
Sabolinski, ML ;
Villagra, VG ;
Winkelmayer, WC ;
Worcel, M .
CIRCULATION, 2005, 112 (24) :3745-3753
[9]   Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J].
Anker, Stefan D. ;
Butler, Javed ;
Filippatos, Gerasimos ;
Ferreira, Joao P. ;
Bocchi, Edimar ;
Boehm, Michael ;
Brunner-La Rocca, Hans-Peter ;
Choi, Dong-Ju ;
Chopra, Vijay ;
Chuquiure-Valenzuela, Eduardo ;
Giannetti, Nadia ;
Gomez-Mesa, Juan Esteban ;
Janssens, Stefan ;
Januzzi, James L. ;
Gonzalez-Juanatey, Jose R. ;
Merkely, Bela ;
Nicholls, Stephen J. ;
Perrone, Sergio V. ;
Pina, Ileana L. ;
Ponikowski, Piotr ;
Senni, Michele ;
Sim, David ;
Spinar, Jindrich ;
Squire, Iain ;
Taddei, Stefano ;
Tsutsui, Hiroyuki ;
Verma, Subodh ;
Vinereanu, Dragos ;
Zhang, Jian ;
Carson, Peter ;
Lam, Carolyn Su Ping ;
Marx, Nikolaus ;
Zeller, Cordula ;
Sattar, Naveed ;
Jamal, Waheed ;
Schnaidt, Sven ;
Schnee, Janet M. ;
Brueckmann, Martina ;
Pocock, Stuart J. ;
Zannad, Faiez ;
Packer, Milton .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1451-1461
[10]   Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. [J].
Anker, Stefan D. ;
Comin Colet, Josep ;
Filippatos, Gerasimos ;
Willenheimer, Ronnie ;
Dickstein, Kenneth ;
Drexler, Helmut ;
Luescher, Thomas F. ;
Bart, Boris ;
Banasiak, Waldemar ;
Niegowska, Joanna ;
Kirwan, Bridget-Anne ;
Mori, Claudio ;
Rothe, Barbara von Eisenhart ;
Pocock, Stuart J. ;
Poole-Wilson, Philip A. ;
Ponikowski, Piotr .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) :2436-2448